All Stories

  1. Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy

    Article • Inflammatory Bowel Diseases, December 2016, Wolters Kluwer Health

    Professor Marco De Andrea, Valeria Caneparo